Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study.
Chiriboga CA, Bruno C, Duong T, Fischer D, Mercuri E, Kirschner J, Kostera-Pruszczyk A, Jaber B, Gorni K, Kletzl H, Carruthers I, Martin C, Warren F, Scalco RS, Wagner KR, Muntoni F; JEWELFISH Study Group. Chiriboga CA, et al. Neurol Ther. 2023 Apr;12(2):543-557. doi: 10.1007/s40120-023-00444-1. Epub 2023 Feb 13. Neurol Ther. 2023. PMID: 36780114 Free PMC article.
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study.
Chiriboga CA, Bruno C, Duong T, Fischer D, Mercuri E, Kirschner J, Kostera-Pruszczyk A, Jaber B, Gorni K, Kletzl H, Carruthers I, Martin C, Warren F, Scalco RS, Wagner KR, Muntoni F; JEWELFISH Study Group. Chiriboga CA, et al. Neurol Ther. 2023 Oct;12(5):1799-1801. doi: 10.1007/s40120-023-00503-7. Neurol Ther. 2023. PMID: 37395990 Free PMC article. No abstract available.
Persistent severe visual field impairment is associated with obesity and tumour invasiveness, but not with pituitary dysfunction, in patients with craniopharyngioma.
Giovinazzo S, Oliverio G, Cotta OR, Alessi Y, Angileri FF, Ferreri F, Certo R, De Maria A, Alibrandi A, Aragona P, Cannavò S, Ferraù F. Giovinazzo S, et al. Among authors: aragona p. Endocrine. 2023 Jul;81(1):50-53. doi: 10.1007/s12020-023-03359-x. Epub 2023 Apr 11. Endocrine. 2023. PMID: 37040006
Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments.
Fogagnolo P, Giannaccare G, Mencucci R, Villani E, Orfeo V, Aragona P; Italian Dry Eye Study Group. Fogagnolo P, et al. Among authors: aragona p. Ophthalmol Ther. 2024 Jan;13(1):251-266. doi: 10.1007/s40123-023-00833-7. Epub 2023 Nov 10. Ophthalmol Ther. 2024. PMID: 37948015 Free PMC article.
One Soul and Several Faces of Evaporative Dry Eye Disease.
Di Zazzo A, Barabino S, Fasciani R, Aragona P, Giannaccare G, Villani E, Rolando M. Di Zazzo A, et al. Among authors: aragona p. J Clin Med. 2024 Feb 21;13(5):1220. doi: 10.3390/jcm13051220. J Clin Med. 2024. PMID: 38592038 Free PMC article. Review.
How gut microbiota may impact ocular surface homeostasis and related disorders.
Labetoulle M, Baudouin C, Benitez Del Castillo JM, Rolando M, Rescigno M, Messmer EM, Aragona P. Labetoulle M, et al. Among authors: aragona p. Prog Retin Eye Res. 2024 May;100:101250. doi: 10.1016/j.preteyeres.2024.101250. Epub 2024 Mar 8. Prog Retin Eye Res. 2024. PMID: 38460758 Free article. Review.
Real-world experience with fluocinolone acetonide intravitreal implant in patients with diabetic macular edema.
Capone L, Airaghi P, Aragona P, Castellino N, Cicinelli MV, Ciucci F, Coppola M, Gaetano C, Lattanzio R, Lorusso M, Maceroni M, Malvasi ME, Marco L, Marraffa M, Martini G, Mastropasqua R, Minnella AM, Nikolopulou E, Ortisi E, Pacella E, Papa V, Pennesi C, Reibaldi M, Rizzo S, Toto L, Trombetta L, Bandello F. Capone L, et al. Among authors: aragona p. Eur J Ophthalmol. 2024 Feb 23:11206721241235266. doi: 10.1177/11206721241235266. Online ahead of print. Eur J Ophthalmol. 2024. PMID: 38396370
188 results